skip to cookie settings skip to content
BridgeBio
  • About
  • Science
  • Pipeline
    • Attruby®

      (acoramidis)

      ↗
    • NULIBRY®

      (fosdenopterin)

      ↗
  • Patients
News
Careers
Investors

Latest

Sidebar content postList

  • All

PRESENTATION · Dec 2021 · PDF

BBIO--CAH-GTx-BBP-631--ASGCT-2021--NHP

PRESENTATION · Dec 2021 · PDF

BBIO--CAH-GTx-BBP-631--ENDO-2021--Phase-1-2-Study-Design

PUBLICATION · May 2021 · PDF

Genetics in Medicine, Achondroplasia Natural History Study (CLARITY): A Multicenter Retrospective Cohort Study of Achondroplasia in the United States

PUBLICATION · Feb 2021 · PDF

Bone, Lifetime Impact of Achondroplasia: Current Evidence and Perspectives on the Natural History

PRESENTATION · Dec 2019 · PDF

BBIO--CAH-GTx-BBP-631--ESGCT-2019--NHP

PUBLICATION · Jan 2019 · PDF

Orphanet Journal of Rare Diseases, Achondroplasia: A Comprehensive Clinical Review

PUBLICATION · Aug 2018 · PDF

Nature Communications, Ribitol Restores Functionally Glycosylated Alpha-dystroglycan and Improves Muscle Function in Dystrophic FKRP-mutant Mice

PUBLICATION · Dec 2016 · PDF

Developmental Dynamics, Achondroplasia: Development, Pathogenesis, and Therapy

PUBLICATION · May 2016

The Journal of Clinical Investigation, Tyrosine Kinase Inhibitor NVP-BGJ398 Functionally Improves FGFR3-related Dwarfism in Mouse Model

  • Previous Page
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Next Page

Breaking news for the achondroplasia community

Positive Topline Phase 3 Data from PROPEL 3, our Study of Oral Infigratinib
Read Press Release

Stay informed.

Company

  • About Us
  • Careers
  • Investors ↗
  • Contact Us

Insights

  • On Rare Podcast ↗
  • News ↗

Science

  • Clinical Trial Info
  • Presentations & Publications
  • Grants & Funding

Medicines & Pipeline

  • Pipeline
  • Attruby® (acoramidis) ↗
  • NULIBRY® (fosdenopterin) ↗

Patients

  • Stories
  • Access
  • Support

Policies

  • Terms of Use
  • Global Privacy Policy
  • Cookies Settings
  • All Policies

Social

  • LinkedIn ↗
  • X ↗
  • Facebook ↗
  • Instagram ↗
  • YouTube ↗
  • TikTok ↗
BridgeBio

This site is intended for U.S. residents.

BridgeBio, Attruby, the Attruby logo, ForgingBridges, and the ForgingBridges logo are trademarks of BridgeBio Pharma, Inc. All other trademarks are property of their respective owners.

© 2026 BridgeBio Pharma, Inc. All rights reserved.